Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening TechnologyGlobeNewsWire • 06/12/24
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024GlobeNewsWire • 06/06/24
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) StudyGlobeNewsWire • 05/29/24
Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective SolutionsGlobeNewsWire • 05/23/24
Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety EventGlobeNewsWire • 05/17/24
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsGlobeNewsWire • 05/08/24
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsGlobeNewsWire • 04/18/24
Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderGlobeNewsWire • 04/11/24
Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCGlobeNewsWire • 03/26/24
Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 03/12/24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 03/11/24
Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024GlobeNewsWire • 03/01/24
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayGlobeNewsWire • 02/28/24
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders' Equity RequirementGlobeNewsWire • 02/16/24
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational HighlightsGlobeNewsWire • 02/09/24
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross ProceedsGlobeNewsWire • 02/05/24
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue ResultsGlobeNewsWire • 02/02/24
Fingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces AcceleratesGlobeNewsWire • 01/30/24
Leading UK Timber Processor and Packaging Manufacturer, James Jones & Sons Ltd., Adopts Intelligent Bio Solutions' Fingerprint Drug Screening System Across its 25 Sites and 1,300 EmployeesGlobeNewsWire • 01/29/24
UK's largest independent chemical manufacturer takes drug testing in-house with Intelligent Fingerprinting Drug Screening SystemGlobeNewsWire • 01/18/24
Intelligent Bio Solutions Receives NATA Accreditation for its Revolutionary Fingerprint Sweat Drug Screening SystemGlobeNewsWire • 12/19/23
Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring StaffGlobeNewsWire • 12/05/23